Subsequent serum testing demonstrated markedly elevated anti-GM-CSF autoantibody levels at 49.9 μg/mL (reference < 3 μg/mL), confirming a diagnosis of autoimmune PAP. Here, CSF2 is linked to autoimmune pulmonary alveolar proteinosis.